William A. Craig - Concepedia

Author

William A. Craig

Also Known As

Canziani, Maria Eugênia Fernandes, Craig,William A, N. Huzjak, P.G. Welling, W A Craig, W. A. Craig, W. Craig, W.A. Craig, WILLIAM A. CRAIG, William A Craig

241

Publications

22.6K

Citations

H-Index

128

Concepts

All Affiliations

University of Wisconsin–Madison William S. Middleton Memorial Veterans Hospital United States Department of Veterans Affairs

About

William A. Craig is an author at University of Wisconsin–Madison specializing in medicine, pharmacology, and antimicrobial resistance.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	41	76	6.4K
2	Health Sciences	22	26	2.6K
3	Allergy	2	2	70
4	Natural Sciences	1	1	40
5	Public Health	1	1	234

William A. Craig

110

Publications

10.4K

Citations

H-Index

Page 1

	Year	Citations
Correlation of Antimicrobial Pharmacokinetic Parameters with Therapeutic Efficacy in an Animal Model Bennett Vogelman, J. E. Leggett, John Turnidge, The Journal of Infectious Diseases	1988	713
Inhibition of Mutation and Combating the Evolution of Antibiotic Resistance Ryan T. Cirz, Jodie K. Chin, David R. Andes, PLoS Biology GeneticsMolecular BiologyAntimicrobial ChemotherapyAntibiotic ResistanceTreatment Resistance	2005	575
In Vivo Pharmacodynamic Activity of Daptomycin Nasia Safdar, David R. Andes, William A. Craig Antimicrobial Agents and Chemotherapy	2003	370
Comparative Antibiotic Dose-Effect Relations at Several Dosing Intervals in Murine Pneumonitis and Thigh-Infection Models J. E. Leggett, B. Fantin, Steven C. Ebert, The Journal of Infectious Diseases Several Dosing IntervalsAntimicrobial ChemotherapyDrug ResistancePharmacological StudyThigh-infection Models	1989	351
Kinetics of antimicrobial activity Bennett Vogelman, William A. Craig The Journal of Pediatrics MedicineAntimicrobial ActivityAntimicrobial TherapyAntimicrobial PharmacokineticsAntibacterial Agent	1986	315
Postantibiotic Suppression of Bacterial Growth R. W. Bundtzen, Andreas Gerber, David L. Cohn, Clinical Infectious Diseases	1981	311
In Vivo Pharmacodynamics of a New Oxazolidinone (Linezolid) David R. Andes, M L van Ogtrop, Jie Peng, Antimicrobial Agents and Chemotherapy	2002	282
In Vivo Postantibiotic Effect in a Thigh Infection in Neutropenic Mice Bennett Vogelman, John Turnidge, J. E. Leggett, The Journal of Infectious Diseases	1988	265
In Vivo Activities of Amoxicillin and Amoxicillin-Clavulanate against <i>Streptococcus pneumoniae</i> : Application to Breakpoint Determinations David R. Andes, William A. Craig Antimicrobial Agents and Chemotherapy	1998	251
Use of Preclinical Data for Selection of a Phase II/III Dose for Evernimicin and Identification of a Preclinical MIC Breakpoint George L. Drusano, Sandra L. Preston, C. Hardalo, Antimicrobial Agents and Chemotherapy	2001	240

Page 1